190 related articles for article (PubMed ID: 24842165)
1. A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity.
Cheng X; Zhang X; Zhou Y; Zhang C; Hua ZC
Cancer Biol Ther; 2014 Aug; 15(8):1068-76. PubMed ID: 24842165
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the PhoP/Q regulon to survival and replication of Salmonella enterica serovar Typhimurium in macrophages.
Thompson JA; Liu M; Helaine S; Holden DW
Microbiology (Reading); 2011 Jul; 157(Pt 7):2084-2093. PubMed ID: 21511762
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Effect of Cycle Inhibiting Factor Expression in Colon Cancer
Liu L; Zhang J; Gu M; Li G; Ni J; Fan M
Anticancer Agents Med Chem; 2020; 20(14):1722-1727. PubMed ID: 32324525
[TBL] [Abstract][Full Text] [Related]
4. Constitutively expressed phoP inhibits mouse-virulence of Salmonella typhimurium in an Spv-dependent manner.
Matsui H; Kawakami T; Ishikawa S; Danbara H; Gulig PA
Microbiol Immunol; 2000; 44(6):447-54. PubMed ID: 10941927
[TBL] [Abstract][Full Text] [Related]
5. PhoP/Q regulated genes in Salmonella typhi identification of melittin sensitive mutants.
Baker SJ; Daniels C; Morona R
Microb Pathog; 1997 Mar; 22(3):165-79. PubMed ID: 9075219
[TBL] [Abstract][Full Text] [Related]
6. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
Chen J; Wei D; Zhuang H; Qiao Y; Tang B; Zhang X; Wei J; Fang S; Chen G; Du P; Huang X; Jiang W; Hu Q; Hua ZC
Mol Cell Proteomics; 2011 Jun; 10(6):M111.009399. PubMed ID: 21474796
[TBL] [Abstract][Full Text] [Related]
7. Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies.
Bereta M; Hayhurst A; Gajda M; Chorobik P; Targosz M; Marcinkiewicz J; Kaufman HL
Vaccine; 2007 May; 25(21):4183-92. PubMed ID: 17399861
[TBL] [Abstract][Full Text] [Related]
8. The PhoP virulence regulon and live oral Salmonella vaccines.
Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
[TBL] [Abstract][Full Text] [Related]
9. Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.
Chen J; Yang B; Cheng X; Qiao Y; Tang B; Chen G; Wei J; Liu X; Cheng W; Du P; Huang X; Jiang W; Hu Q; Hu Y; Li J; Hua ZC
Cancer Sci; 2012 Feb; 103(2):325-33. PubMed ID: 22054098
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.
Tian Y; Guo B; Jia H; Ji K; Sun Y; Li Y; Zhao T; Gao L; Meng Y; Kalvakolanu DV; Kopecko DJ; Zhao X; Zhang L; Xu D
Cancer Gene Ther; 2012 Jun; 19(6):393-401. PubMed ID: 22555509
[TBL] [Abstract][Full Text] [Related]
11. Attenuated Salmonella VNP20009 mutant (ΔhtrA) is a promising candidate for bacteria-mediated tumour therapy in hosts with TNFR1 deficiency.
Xu W; Zhou T; Zhou J; Qiang Z; Zhang J; Hua Z
Lett Appl Microbiol; 2018 Jul; 67(1):97-103. PubMed ID: 29698572
[TBL] [Abstract][Full Text] [Related]
12. A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells.
Behlau I; Miller SI
J Bacteriol; 1993 Jul; 175(14):4475-84. PubMed ID: 8392513
[TBL] [Abstract][Full Text] [Related]
13. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.
Miller SI; Kukral AM; Mekalanos JJ
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5054-8. PubMed ID: 2544889
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors.
Yang N; Li SH; Lü YZ; Chen LS; Ren DM
Acta Pharmacol Sin; 2011 Mar; 32(3):368-74. PubMed ID: 21372828
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.
Angelakopoulos H; Hohmann EL
Infect Immun; 2000 Apr; 68(4):2135-41. PubMed ID: 10722611
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and efficacy of tumor-targeting
Zhang Y; Cao W; Toneri M; Zhang N; Kiyuna T; Murakami T; Nelson SD; Dry SM; Li Y; Li S; Wang X; Ma H; Singh AS; Eilber FC; Hoffman RM; Zhao M
Oncotarget; 2017 Aug; 8(33):54616-54628. PubMed ID: 28903369
[No Abstract] [Full Text] [Related]
17. Effect of Salmonella enterica serovar Typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression.
Coutermarsh-Ott SL; Broadway KM; Scharf BE; Allen IC
Oncotarget; 2017 May; 8(20):33601-33613. PubMed ID: 28431394
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages.
Miller SI; Mekalanos JJ
J Bacteriol; 1990 May; 172(5):2485-90. PubMed ID: 2185222
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.
Zhang Y; Zhang N; Zhao M; Hoffman RM
Oncotarget; 2015 Jun; 6(16):14625-31. PubMed ID: 25714030
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific delivery of histidine-rich glycoprotein suppresses tumor growth and metastasis by anti-angiogenesis and vessel normalization.
Cheng X; Zhang X; Cheng W; Chen J; Ma C; Yang B; Hua ZC
Curr Gene Ther; 2014; 14(2):75-85. PubMed ID: 24606115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
